Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Direct ✕Aditya Birla Sun Life Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundAditya Birla Sun Life Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseNippon IndiaABSL
NAV₹666.3420₹17.3800
NAV date20 Nov 202619 Nov 2026
History13.9 years4.9 years
Expense ratio1.0%1.5%
Stars★★★★★★★★★★
Growth Score75.2058.40

Returns

Nippon India Pharma FundAditya Birla Sun Life Business Cycle Fund
1 month+11.40%+5.46%
3 months+3.74%−0.06%
6 months+8.55%+11.41%
YTD+16.94%+5.98%
1 year+15.26%+5.53%
3 years (CAGR)+17.96%+13.55%
5 years (CAGR)+15.40%—
10 years (CAGR)+16.61%—
Since launch+17.63%+11.61%

Risk

Nippon India Pharma FundAditya Birla Sun Life Business Cycle Fund
Volatility14.1%15.3%
Downside volatility9.0%10.4%
Sharpe0.810.46
Sortino1.280.68
Calmar1.220.76
Return / risk1.270.88
Deepest fall−24.02%−17.78%
Days to recover445490
Below its high+0.00%−1.75%

Against benchmark

Nippon India Pharma FundAditya Birla Sun Life Business Cycle Fund
Alpha−1.86%+1.91%
Beta0.890.92
R²89.5%92.8%
Up capture85.2%102.6%
Down capture88.7%94.4%
Tracking error4.8%4.3%
Information ratio−0.690.34
Treynor0.120.07

Consistency

Nippon India Pharma FundAditya Birla Sun Life Business Cycle Fund
Best 1-year+90.70%+41.47%
Middle 1-year+13.13%+10.16%
Worst 1-year−15.12%−6.80%
1-year periods with a loss23.2%6.8%
Middle 3-year+19.82%+14.52%
Positive months63.9%66.7%
Best day+3.40%+3.90%
Worst day−3.21%−5.64%
Worst 5% day−1.38%−1.39%
Positive days53.7%55.1%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundAditya Birla Sun Life Business Cycle Fund
5-year XIRR+18.24%—
5-year value₹9,54,076—
3-year XIRR+14.26%+9.19%
1-year XIRR+22.08%+12.24%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth